Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
Both programs have successfully escalated to dose levels demonstrating pharmacodynamic activity without dose–limiting toxicities Detailed…
Why Mid-Sized Enterprises Are Struggling With AI Integration and How IT Leaders Can Fix the Architecture Gap in 2026
New Survey Highlights Gap Between Perceived AI Readiness And Tested Disaster Recovery Capability
Syngenta Deploys Tetra OS to Accelerate Scientific Discovery Through Industrial-Scale Data Automation